APA (7th ed.) Citation

S, T., E, W., Y, L., F, Z., & M, E. (2026). Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years. Obesity surgery, 36(2), 376. https://doi.org/10.1007/s11695-025-08467-3

Chicago Style (17th ed.) Citation

S, Thiyagarajan, Wall-Wieler E, Liu Y, Zheng F, and Edwards M. "Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists Is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years." Obesity Surgery 36, no. 2 (2026): 376. https://doi.org/10.1007/s11695-025-08467-3.

MLA (9th ed.) Citation

S, Thiyagarajan, et al. "Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists Is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years." Obesity Surgery, vol. 36, no. 2, 2026, p. 376, https://doi.org/10.1007/s11695-025-08467-3.